ArticleBrain : a journal of neurology2026

Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study.

Ling-Ling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.